Integral Health Asset Management’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-250,000
| Closed | -$4.28M | – | 85 |
|
|
2023
Q3 | $4.28M | Sell |
250,000
-195,000
| -44% | -$3.34M | 0.59% | 53 |
|
|
2023
Q2 | $10.3M | Buy |
445,000
+50,000
| +13% | +$1.16M | 1.28% | 31 |
|
|
2023
Q1 | $6.98M | Buy |
395,000
+175,000
| +80% | +$3.09M | 1.41% | 31 |
|
|
2022
Q4 | $5.98M | Buy |
220,000
+20,000
| +10% | +$544K | 1.26% | 29 |
|
|
2022
Q3 | $3.45M | Sell |
200,000
-19,194
| -9% | -$331K | 0.67% | 52 |
|
|
2022
Q2 | $3.83M | Buy |
219,194
+54,194
| +33% | +$947K | 0.79% | 44 |
|
|
2022
Q1 | $2.8M | Buy |
165,000
+65,000
| +65% | +$1.1M | 0.73% | 49 |
|
|
2021
Q4 | $2.71M | Buy |
100,000
+10,000
| +11% | +$271K | 0.75% | 44 |
|
|
2021
Q3 | $2.67M | Hold |
90,000
| – | – | 0.77% | 50 |
|
|
2021
Q2 | $3.46M | Buy |
90,000
+19,000
| +27% | +$730K | 0.95% | 41 |
|
|
2021
Q1 | $2.17M | Buy |
71,000
+23,500
| +49% | +$717K | 0.62% | 51 |
|
|
2020
Q4 | $1.81M | Buy |
+47,500
| New | +$1.81M | 0.54% | 48 |
|